Skip to main content

Animations

MJFF Publications

5311 - 5320 of 8586 Results
Title
Year
  • Year
  • 2017
  • 2016
  • 2017
  • 2018
  • 2016
  • 2014
  • 2018
  • 2018
  • 2017
  • 2011
  • Summary Details
    RESTRICTED
    Title: Distinct metabolomic signature in cerebrospinal fluid in early parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27132
    Citation Count: 107
  • Summary Details
    OPEN
    Title: LRRK2 and RAB7L1 coordinately regulate axonal morphology and lysosome integrity in diverse cellular contexts
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/srep29945
    Citation Count: 127
  • Summary Details
    OPEN
    Title: Phosphorylated exogenous alpha-synuclein fibrils exacerbate pathology and induce neuronal dysfunction in mice
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-017-15813-8
    Citation Count: 138
  • Summary Details
    OPEN
    Title: Global quantitative analysis of the human brain proteome in Alzheimer’s and Parkinson’s Disease
    Journal Name: Scientific Data
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/sdata.2018.36
    Citation Count: 214
  • Summary Details
    OPEN
    Title: Human whole genome genotype and transcriptome data for Alzheimer’s and other neurodegenerative diseases
    Journal Name: Scientific Data
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/sdata.2016.89
    Citation Count: 427
  • Summary Details
    OPEN
    Title: Quantitative Measurement of Intact Alpha-Synuclein Proteoforms from Post-Mortem Control and Parkinson's Disease Brain Tissue by Intact Protein Mass Spectrometry
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1038/srep05797
    Citation Count: 155
  • Summary Details
    OPEN
    Title: Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-018-0062-4
    Citation Count: 78
  • Summary Details
    OPEN
    Title: Prevalence of Parkinson’s disease across North America
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-018-0058-0
    Citation Count: 844
  • Summary Details
    OPEN
    Title: LRRK2 levels in immune cells are increased in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-017-0010-8
    Citation Count: 237
  • Summary Details
    OPEN
    Title: Neurologist care in Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e31822c9123
    Citation Count: 265
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.